Dr. Victoria “Vickie” Keck is Acting Associate Director for Generic Drug Stakeholder and Global Engagement at the FDA’s Office of Generic Drugs (OGD), where she leads outreach and international collaboration efforts to advance generic drug regulatory science and policy. In this role, she cultivates strategic partnerships with scientific communities and international regulatory agencies, and directs OGD’s participation in global harmonization initiatives.
Vickie brings nearly 25 years of experience at the intersection of science, medicine, and regulatory decision-making. Trained in comparative medicine, she applies a One Health framework, recognizing the interconnectedness of human, animal, and environmental health, to translational and regulatory science. Since joining OGD in 2015, her contributions have spanned pharmacology/toxicology review, international scientific exchange, and complex cross-agency issues, including nitrosamine risk assessment.
A recognized leader and innovator, Vickie developed and launched an international scientific exchange program and has served as a mentor and leader at FDA for over a decade. She holds a VMD from the University of Pennsylvania School of Veterinary Medicine, a Master’s in Biotechnology/Bioinformatics from Johns Hopkins University, and completed a residency in laboratory animal and comparative medicine at Vanderbilt University Medical Center.
